Biomarkers for cervical cancer

Gijsbertha Barendina Alida Wisman; Ate Gerard Jan van der Zee; Eduardus Maria Dominicus Schuuring

Biomarkers for cervical cancer

Gijsbertha Barendina Alida Wisman (Inventor), Ate Gerard Jan van der Zee (Inventor), Eduardus Maria Dominicus Schuuring (Inventor)

Research output: Patent

Abstract

The invention relates to methods, reagents and kits for detecting the susceptibility to cervical cancer. In particular, it relates to novel methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3 (CIN2/3) and the use thereof for identifying a cervical cell as neoplastic or predisposed to neoplasia in an isolated sample.

Original language	English
Patent number	WO2016048138
Priority date	22/09/2014
Publication status	Published - 31-Mar-2016

Access to Document

https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2016048138A1&KC=A1&FT=D&ND=3&date=20160331&DB=&locale=en_EP

Cite this

@misc{f4bdaa4be8734d1eab72412b926a7de5,

title = "Biomarkers for cervical cancer",

abstract = "The invention relates to methods, reagents and kits for detecting the susceptibility to cervical cancer. In particular, it relates to novel methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3 (CIN2/3) and the use thereof for identifying a cervical cell as neoplastic or predisposed to neoplasia in an isolated sample.",

author = "Wisman, {Gijsbertha Barendina Alida} and {van der Zee}, {Ate Gerard Jan} and Schuuring, {Eduardus Maria Dominicus}",

year = "2016",

month = mar,

day = "31",

language = "English",

type = "Patent",

note = "WO2016048138",

}

TY - PAT

T1 - Biomarkers for cervical cancer

AU - Wisman, Gijsbertha Barendina Alida

AU - van der Zee, Ate Gerard Jan

AU - Schuuring, Eduardus Maria Dominicus

PY - 2016/3/31

Y1 - 2016/3/31

N2 - The invention relates to methods, reagents and kits for detecting the susceptibility to cervical cancer. In particular, it relates to novel methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3 (CIN2/3) and the use thereof for identifying a cervical cell as neoplastic or predisposed to neoplasia in an isolated sample.

AB - The invention relates to methods, reagents and kits for detecting the susceptibility to cervical cancer. In particular, it relates to novel methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3 (CIN2/3) and the use thereof for identifying a cervical cell as neoplastic or predisposed to neoplasia in an isolated sample.

M3 - Patent

M1 - WO2016048138

ER -